| 000 | 01551 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517141750.0 | ||
| 264 | 0 | _c20170508 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1420-3049 | ||
| 024 | 7 |
_a10.3390/molecules22030334 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Jun-Xia | |
| 245 | 0 | 0 |
_aLuteolin Inhibits Fibrillary β-Amyloid _h[electronic resource] |
| 260 |
_bMolecules (Basel, Switzerland) _cFeb 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xadverse effects |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aAstrocytes _xcytology |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCoculture Techniques |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteolin _xpharmacology |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xadverse effects |
| 700 | 1 | _aXing, Jian-Guo | |
| 700 | 1 | _aWang, Lin-Lin | |
| 700 | 1 | _aJiang, Hai-Lun | |
| 700 | 1 | _aGuo, Shui-Long | |
| 700 | 1 | _aLiu, Rui | |
| 773 | 0 |
_tMolecules (Basel, Switzerland) _gvol. 22 _gno. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/molecules22030334 _zAvailable from publisher's website |
| 999 |
_c26921810 _d26921810 |
||